Blog

Drug legislation has never been a neutral or purely scientific matter of public health or criminal justice. Rather, drug laws have long functioned as mechanisms of social control deeply embedded in racialised and colonial systems of domination.

London Drugs Commission (LDC) has released its report on cannabis policy, offering a pragmatic middle ground between full legalisation and the failed status quo of prohibition. While some advocates may argue the recommendations don’t go far enough, this report represents a critical step in the right direction—one that deserves support

Kava is a culturally significant Pacific drink used traditionally with cultural practice as a relaxant, to promote dialog in group settings, to aid in sleep and to manage anxiety. Its anxiolytic and sedative properties may link to the presence of kavalactones which are putative low potency GABA ligands.

The whole Drug Science Team is shocked and incredibly saddened by the news of Hannah Deacon’s passing on May 6th, 2025, after ‘a short and brutal illness’

Stigmatised attitudes, opinions on opioid use, and prior contact with People Who Use Drugs (PWUD) contribute to what policies are publicly supported and implemented to reduce drug-related deaths. This study examined how these variables relate to policy support for the implementation of supervised injection sites, laws protecting bystanders at the scene of an overdose, and over-the-counter naloxone.

We sought to examine nascent trends surrounding the impacts of police drug seizures in the period after a substantial public policy shift surrounding the personal possession of drugs in British Columbia (BC), Canada. We explored the intersection of drug testing and police opioid seizures in Vancouver, BC.

The CPRG officially marked its launch by hosting the 1st Cambridge Psychedelic Research Day on March 12, 2025 at Clare College, the University of Cambridge’s second-oldest college, founded in 1326.

I recently had the privilege of attending a gathering focused on psychedelics hosted by the University of Auckland. Events like these contribute to sensible and informed debate about important issues - like the development of psychedelic therapy.

As our societies grapple with environmental and mental health challenges, investigating potential avenues for restoring relations with nature is more important than ever.

The global regulatory landscape for psilocybin and PSILO-AT remains highly variable, with significant differences in the scope and clarity of medical governance.

Although there is growing support for the protective effects of psychedelics on mental health, recent evidence finds racial and ethnic minorities gain fewer benefits.

The increasing incidence of opioid dependence linked to the consumption of unwashed poppy seeds (UPSs) is an emerging public health concern.

The increasing incidence of opioid dependence linked to the consumption of unwashed poppy seeds (UPSs) is an emerging public health concern.

A recent meta-analysis in Drug Science, Policy and Law on the risk associated with the detection of tetrahydrocannabinol (THC) in blood and

Last week, the Ukrainian Ministry of Health took an important step toward enabling scientific research with psychedelics.

When the email invite came I thought it was a hoax so I contacted Wolf Singer – another neuroscientist. He reassured me it was for real, an

On the 26th of February 2025, Clive Bates wrote to an academic at Manchester Metropolitan University, Dr Maxime Boidin, about generating irr

The past 50 years have seen remarkable advances in the science of medicine. The pharmacological treatments of disorders such as hypertension

Despite recent setbacks for the clinical application of MDMA, the chapter argues that it holds potential for transforming psychiatry and

This paper discusses the topic of safer injecting facilities with those who are likely to use them. Whilst more countries are adopting this

The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4-methylenedioxymethamphetamine (MDMA)

This article discusses the introduction of the safe drug consumption facility in Glasgow and considers some of its potential consequences.